Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil
Clinical trial NCT07163845 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07163845
- Sponsor
- Valneva Austria GmbH
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-09-22
- Primary completion
- 2026-07-31
- Enrollment
- 5354
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.